What was the financial impact of the HCA Merger, and why do the reported numbers differ?

The HCA Merger was completed on February 10, 1994, and is accounted for as a pooling of interests. The primary financial statements reflect pre-merger Columbia only (1993 net income of $139 million), while the supplemental statements restate the combined entity as if the merger had always occurred (1993 net income of $507 million). Investors should use the combined figures to assess the enlarged company, though the merger's first-quarter 1994 costs and refinancing losses (about $80 million) will reduce near-term earnings.

How exposed is the Company to Medicare and government reimbursement changes?

Highly exposed. Medicare made up 34% of combined patient revenues in 1993, and Medicaid another 4%. DRG rate increases have lagged inflation, with the FY1994 urban update at market basket minus 2.5%. Management expects only about 2% Medicare payment growth in 1994. Pending federal health care reform and Gramm-Rudman spending cuts could reduce payments further, and the filing explicitly says future Medicare rates may not cover cost increases.

What are the main risks to earnings and the balance sheet?

Key risks include declining hospital occupancy (45% combined), margin pressure from payer mix shifts toward discounted managed care, and rising labor and supply costs. On the balance sheet, combined long-term debt is about $3.7 billion, and the company relies on commercial paper backed by $3 billion of revolving credit facilities. Professional liability reserves total $817 million. The contested IRS claims, if upheld in full, would be materially adverse to results, financial position and liquidity.

How did the Company's dividend and share structure change?

The Company began paying a quarterly dividend of $0.03 per share in late 1993 and expects to continue it after the HCA Merger. Following the merger, common shares rose to about 336.7 million voting and nonvoting shares combined (pro forma), up from roughly 151 million pre-merger Columbia shares. Authorized voting common stock was increased from 400 million to 800 million, and the company was renamed Columbia/HCA Healthcare Corporation. The Company's stock trades on the NYSE under the symbol COL.

What growth drivers does management emphasize?

Management pursues a strategy of acquiring mid- to large-size general acute care hospitals in targeted markets, then building comprehensive networks that include psychiatric, outpatient surgery, diagnostic, rehabilitation and home health services. It also emphasizes physician co-ownership of facilities and positioning for managed care contracts with HMOs and PPOs. Growth in 1993 came mainly from price increases, acquisitions and outpatient volume, while same-hospital inpatient admissions declined. The Company acquired three hospitals in 1993 and expended $114 million on four additional hospitals after year-end 1993.

HCA 10-K FY1993 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed March 31, 1994. Cited figures are marked; the original filing is the authoritative source.

Columbia/HCA Healthcare Corporation (the Company) is a hospital operator that, as of March 28, 1994, ran 196 hospitals in 26 states and two foreign countries.

The filing covers the 1993 fiscal year, but the reported figures are those of Columbia Healthcare Corporation alone (pre-HCA Merger), with a separate supplemental presentation that combines Columbia and HCA as if the February 10, 1994 HCA Merger (a pooling of interests) had occurred earlier. On the pre-merger Columbia basis, 1993 revenues were $5.13 billion^a (up 7%), net income was $139 million ($0.92 per share), and income from continuing operations was $193 million, depressed by $151 million of non-recurring Galen Merger charges. On the combined basis, revenues were $10.25 billion, net income $507 million ($1.50 per share), and EBDITA $2.0 billion with a 19.5% margin.

The key investor concerns are margin pressure and reimbursement risk. Medicare represented 34%^b of combined revenues in 1993 (up from 30% in 1992), and management expects Medicare prospective payment increases of only about 2% in 1994. Medicaid is about 4% of revenues.

Admissions were roughly flat, and occupancy fell to 45%^c combined. Growth has come from outpatient services, which rose to 27% of patient revenues, and from price increases. President Clinton's health care reform proposal, introduced in November 1993, could significantly reduce future provider payments.

Balance sheet leverage and contingent liabilities are also significant. Combined long-term debt was about $3.7 billion^d, and the combined debt-to-capital ratio was 52%. The Company faces roughly $1.3 billion in disputed IRS claims for prior years, which management believes will not be material but which would be materially adverse if upheld.

The HCA Merger and refinancing are expected to reduce first-quarter 1994 net income by about $80 million. Pre-merger Columbia's cash flow from continuing operations was $493 million, down from $668 million in 1992.

02—Key points

Key Highlights

Pro forma combined scale (with HCA, pooling basis): 196 hospitals, 1993 revenues of $10.25 billion, and net income of $507 million ($1.50 per share), versus pre-merger Columbia's standalone revenues of $5.13 billion and net income of $139 million.
Margin and volume pressure: combined EBDITA rose 4% to $2.0 billion, but margins only improved slightly to 19.5%. Same-hospital admissions fell 1.1%, and average occupancy declined to 45% from 47%.
Medicare exposure is rising: Medicare was 34% of combined patient revenues in 1993 (30% in 1992), and the FY1994 DRG update is only 1.8%, roughly market basket minus 2.5%. OBRA 1993 further cuts urban DRG updates to market basket minus 2.5% for FY1995 and minus 2.0% for FY1996.
Large contingent tax exposure: the IRS is contesting roughly $1.3 billion of taxes and interest for prior years. Management expects no material adverse outcome, but an adverse resolution of the majority of claims would be materially harmful.
Leverage and refinancing: combined long-term debt was $3.7 billion, and the debt-to-capital ratio was about 52%. Post-merger refinancing, funded with $3 billion of revolving credit and commercial paper, is expected to cut Q1 1994 net income by about $80 million.
Growth strategy: the Company is building integrated health networks in targeted markets through acquisitions and outpatient expansion. Outpatient revenues rose to 27% of patient revenues, and capital expenditures are planned at about $800 million (combined) for 1994.
Legal and regulatory risk: the filing discloses several class actions (including a securities suit tied to the 1992 IPO and the Humana/Sunrise antitrust and RICO litigation) and a federal regulatory review of physician financial arrangements at two psychiatric hospitals.

03—Questions

Frequently Asked Questions

What was the financial impact of the HCA Merger, and why do the reported numbers differ?
The HCA Merger was completed on February 10, 1994, and is accounted for as a pooling of interests. The primary financial statements reflect pre-merger Columbia only (1993 net income of $139 million), while the supplemental statements restate the combined entity as if the merger had always occurred (1993 net income of $507 million). Investors should use the combined figures to assess the enlarged company, though the merger's first-quarter 1994 costs and refinancing losses (about $80 million) will reduce near-term earnings.
How exposed is the Company to Medicare and government reimbursement changes?
Highly exposed. Medicare made up 34% of combined patient revenues in 1993, and Medicaid another 4%. DRG rate increases have lagged inflation, with the FY1994 urban update at market basket minus 2.5%. Management expects only about 2% Medicare payment growth in 1994. Pending federal health care reform and Gramm-Rudman spending cuts could reduce payments further, and the filing explicitly says future Medicare rates may not cover cost increases.
What are the main risks to earnings and the balance sheet?
Key risks include declining hospital occupancy (45% combined), margin pressure from payer mix shifts toward discounted managed care, and rising labor and supply costs. On the balance sheet, combined long-term debt is about $3.7 billion, and the company relies on commercial paper backed by $3 billion of revolving credit facilities. Professional liability reserves total $817 million. The contested IRS claims, if upheld in full, would be materially adverse to results, financial position and liquidity.
How did the Company's dividend and share structure change?
The Company began paying a quarterly dividend of $0.03 per share in late 1993 and expects to continue it after the HCA Merger. Following the merger, common shares rose to about 336.7 million voting and nonvoting shares combined (pro forma), up from roughly 151 million pre-merger Columbia shares. Authorized voting common stock was increased from 400 million to 800 million, and the company was renamed Columbia/HCA Healthcare Corporation. The Company's stock trades on the NYSE under the symbol COL.
What growth drivers does management emphasize?
Management pursues a strategy of acquiring mid- to large-size general acute care hospitals in targeted markets, then building comprehensive networks that include psychiatric, outpatient surgery, diagnostic, rehabilitation and home health services. It also emphasizes physician co-ownership of facilities and positioning for managed care contracts with HMOs and PPOs. Growth in 1993 came mainly from price increases, acquisitions and outpatient volume, while same-hospital inpatient admissions declined. The Company acquired three hospitals in 1993 and expended $114 million on four additional hospitals after year-end 1993.

04—Continue

← View all 10-K filings